Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron.

Paternina-Caicedo A., Quevedo DS., Ríos DS., Moyano D., Alvis-Guzmán N., Alviz-Zakzuk NR., Salcedo F., Ramírez-Suarez J., Smith AD., De la Hoz-Restrepo F.

DOI

10.1016/j.jinf.2024.106165

Type

Journal article

Publication Date

2024-06-01T00:00:00+00:00

Volume

88

Keywords

Humans, BNT162 Vaccine, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Immunization, Secondary, Antibodies, Viral, Adult, Antibodies, Neutralizing

Permalink More information Close